Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

STEFAN STEFANOVIC; RALPH WIRTZ; MARC SÜTTERLIN; UROS KARIC; ANDREAS SCHNEEWEISS; THOMAS M. DEUTSCH; MARKUS WALLWIENER

doi:10.21873/anticanres.16293

Research ArticleExperimental Studies

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH and MARKUS WALLWIENER

Anticancer Research April 2023, 43 (4) 1449-1454; DOI: https://doi.org/10.21873/anticanres.16293

STEFAN STEFANOVIC

1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: stefan.stefanovic@umm.de

RALPH WIRTZ

2Stratifyer Molecular Pathology GmbH, Cologne, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MARC SÜTTERLIN

1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

UROS KARIC

3Medical Statistics, IMDI Science Center, Belgrade, Serbia;

4Hospital for Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

ANDREAS SCHNEEWEISS

5National Center for Tumor Diseases, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany;

6German Cancer Research Center (DKFZ), Heidelberg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

THOMAS M. DEUTSCH

7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

MARKUS WALLWIENER

7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Log in using your username and password

Username *

Password *

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles

PreviousNext

In this issue

Anticancer Research

Vol. 43, Issue 4

April 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

Message Subject (Your Name) has sent you a message from Anticancer Research

Message Body (Your Name) thought you would like to see the Anticancer Research web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 5 + 7 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER

Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Reprints and Permissions

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER

Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

breast cancer
HLA-A
HLA-B/C
cut-off
prognosticator

Main menu

User menu

Search

Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer

Purchase access

patientACCESS

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords